• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Is Avoidable Experiment Expenditure Draining Billions from COVID-19 Research? fiercepharma
    August 26, 2020
    The rise of COVID-19 represents an unprecedented situation for pharma. With the scramble to find a vaccine, R&D productivity is more important than ever, which makes it especially concerning that pharma still struggles with a widely recognized productivit
  • Pharma R&D productivity hits new low amid rising costs pharmaphorum
    December 20, 2018
    Returns on pharma R&D investment are at a nine-year low, and the cost of developing a drug has nearly doubled since 2010, according to Deloitte’s yearly assessment of the industry’s pipeline productivity.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service